Chronic Obstructive Pulmonary Disease Treatment Market - Global Industry Upcoming Trends, Growth Drivers, Opportunities and Challenges 2018 -2026: to Reach US$ 25,059.1 Mn at a CAGR of 4.7%

This report analyzes the current and future scenario of the global chronic obstructive pulmonary disease (COPD) treatment market. The rise in the prevalence of COPD, an increase in the adoption of combination therapy, and the surge in awareness about COPD treatment are the key factors anticipated to drive the global market. Additionally, an increase in the geriatric population, rise in importance of COPD management, and surge in the number of respiratory care centers contribute to the growth of the global market. According to the Global Initiative for Asthma (GINA) 2018, COPD is the third leading cause of death in the U.S., with a large portion of the population being undiagnosed.

Request Free Sample Copy of Report @ https://www.researchmoz.us/enquiry.php?type=S&repid=2160561

The global chronic obstructive pulmonary disease treatment market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on drug class, distribution channel, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global chronic obstructive pulmonary disease treatment market.

New drug development by market players through collaborations and increase in research and development expenditure are anticipated to drive the global market. In February 2016, Propeller Health and Novartis Pharma AG entered into a collaboration to develop a custom add-on sensor for the Breezhaler inhaler, a device indicated for COPD treatments. This collaboration aims to connect these medications to Propeller’s digital health platform.

Global Chronic Obstructive Pulmonary Disease Treatment Market: Key Segments

In terms of drug class, the global chronic obstructive pulmonary disease treatment market has been segmented into a combination, bronchodilators, corticosteroids, phosphodiesterase type 4 inhibitors, mucokineticsm, and others. The combination segment has been divided into long-acting muscarinic antagonist & inhaled corticosteroids (LAMA-ICS), long-acting beta-agonist & inhaled corticosteroids (LABA-ICS), triple therapy, and others. The bronchodilators segment has been classified into long-acting beta agonist (LABA), short-acting beta agonist (SABA), and long-acting muscarinic antagonist (LAMA). Based on the distribution channel, the market has been categorized into hospital pharmacies, retail pharmacies, and online pharmacies. The retail pharmacies segment is projected to expand at the fastest CAGR due to the increase in the number of patients preferring retail pharmacies. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Chronic Obstructive Pulmonary Disease Treatment Market: Regional Outlook

In terms of region, the global chronic obstructive pulmonary disease treatment market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, Israel, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in the Report

The report also profiles major players in the global chronic obstructive pulmonary disease treatment market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Key players profiled in the market report include AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline plc, Novartis AG, CHIESI Farmaceutici S.p.A., Sunovion Pharmaceuticals, Inc. (Sumitomo Dainippon Pharma Co., Ltd), Teva Pharmaceutical Industries Ltd, Mylan N.V., and Orion Corporation.
The global chronic obstructive pulmonary disease treatment market has been segmented as below:

Contact For Any Query or to Get Customized Report: https://www.researchmoz.us/enquiry.php?type=E&repid=2160561

Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
Combination
--Long-Acting Muscarinic Antagonist & Inhaled Corticosteroids (LAMA-ICS)
--Long Acting Beta Agonist & Inhaled Corticosteroids (LABA-ICS)
--Triple Therapy
--Others

Bronchodilators
--Long Acting Beta Agonist (LABA)
--Short-Acting Beta Agonist (SABA)
--Long-Acting Muscarinic Antagonist (LAMA)

Corticosteroids
--Phosphodiesterase Type 4 Inhibitors
--Mucokinetics
--Others

Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
-
Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Region
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- India
- China
- Japan
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Israel
- Rest of Middle East & Africa

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

ResearchMoz
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ https://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
For More Reports Visit @ http://marketresearchlatestreports.blogspot.com/

This release was published on openPR.